Diabetes 51:860-862, 2002
© 2002 by the American Diabetes Association, Inc.
Human Resistin Gene, Obesity, and Type 2 Diabetes
Mutation Analysis and Population Study
Federica Sentinelli1,
Stefano Romeo1,
Marcello Arca2,
Emanuela Filippi1,
Frida Leonetti1,
Michela Banchieri1,
Umberto Di Mario1, and
Marco Giorgio Baroni1
1 Department of Clinical Sciences, Division of Endocrinology, University of Rome "La Sapienza," Rome, Italy
2 Institute of Terapia Medica Sistematica, University of Rome "La Sapienza," Rome, Italy
The hormone resistin has been suggested to link obesity to type 2 diabetes by modulating steps in the insulin-signaling pathway and inducing insulin resistance. Thus, the resistin gene represents a potential candidate for the etiology of insulin resistance and type 2 diabetes. In this study, we analyzed the coding sequence of the three exons of the resistin gene, together with its 5' regulatory region and 3' untranslated region (UTR), by single-strand conformation polymorphism (SSCP) in 58 type 2 diabetic subjects, 59 obese subjects, and 60 normal subjects. Only one sequence variant was detected in the resistin gene. Sequencing of this variant revealed the presence of a single nucleotide substitution (SNP) in the 3'-UTR of exon 3 (G1326C). Because 3'-UTR SNPs have been shown to affect gene expression, we examined the frequency of this SNP in 591 subjects (198 obese subjects, 207 diabetic subjects, and 186 control subjects) by PCR amplification and BseRI digestion. No significant association was found between the G1326C variant and diabetes and obesity. Comparison of clinical and metabolic parameters between G1326C carriers and noncarriers again showed no significant difference. In conclusion, our data suggest that genetic defects of the resistin gene are unlikely to play a role in the etiology of these common disorders in our population.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Musaad and E. N. Haynes
Biomarkers of Obesity and Subsequent Cardiovascular Events
Epidemiol. Rev.,
May 10, 2007;
(2007)
mxm005v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-M. Seow, C.-C. Juan, L.-T. Ho, Y.-P. Hsu, Y.-H. Lin, L.-W. Huang, and J.-L. Hwang
Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome
Hum. Reprod.,
April 1, 2007;
22(4):
1100 - 1106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Graveleau, V. G. Zaha, A. Mohajer, R. R. Banerjee, N. Dudley-Rucker, C. M. Steppan, M. W. Rajala, P. E. Scherer, R. S. Ahima, M. A. Lazar, et al.
Mouse and Human Resistins Impair Glucose Transport in Primary Mouse Cardiomyocytes, and Oligomerization Is Required for This Biological Action
J. Biol. Chem.,
September 9, 2005;
280(36):
31679 - 31685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E Krassas, N. Pontikides, K. Loustis, G. Koliakos, T. Constantinidis, and D. Panidis
Resistin levels in hyperthyroid patients before and after restoration of thyroid function: relationship with body weight and body composition
Eur. J. Endocrinol.,
August 1, 2005;
153(2):
217 - 221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Kim, H.-J. Kim, S.-Y. Park, A. Cederberg, R. Westergren, D. Nilsson, T. Higashimori, Y.-R. Cho, Z.-X. Liu, J. Dong, et al.
Adipocyte-Specific Overexpression of FOXC2 Prevents Diet-Induced Increases in Intramuscular Fatty Acyl CoA and Insulin Resistance
Diabetes,
June 1, 2005;
54(6):
1657 - 1663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-M. Seow, C.-C. Juan, L.-Y. Wu, Y.-P. Hsu, W.-M. Yang, Y.-L. Tsai, J.-L. Hwang, and L.-T. Ho
Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance
Hum. Reprod.,
January 1, 2004;
19(1):
48 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Lee, J. L. Chan, N. Yiannakouris, M. Kontogianni, E. Estrada, R. Seip, C. Orlova, and C. S. Mantzoros
Circulating Resistin Levels Are Not Associated with Obesity or Insulin Resistance in Humans and Are Not Regulated by Fasting or Leptin Administration: Cross-Sectional and Interventional Studies in Normal, Insulin-Resistant, and Diabetic Subjects
J. Clin. Endocrinol. Metab.,
October 1, 2003;
88(10):
4848 - 4856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Smith, F. Bai, C. Charbonneau, L. Janderova, and G. Argyropoulos
A Promoter Genotype and Oxidative Stress Potentially Link Resistin to Human Insulin Resistance
Diabetes,
July 1, 2003;
52(7):
1611 - 1618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-S. Tan, S.-Y. Chang, D.-M. Chang, J. C.-R. Tsai, and Y.-J. Lee
Association of Resistin Gene 3'-Untranslated Region +62G->A Polymorphism with Type 2 Diabetes and Hypertension in a Chinese Population
J. Clin. Endocrinol. Metab.,
March 1, 2003;
88(3):
1258 - 1263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Urbanek, Y. Du, K. Silander, F. S. Collins, C. M. Steppan, J. F. Strauss III, A. Dunaif, R. S. Spielman, and R. S. Legro
Variation in Resistin Gene Promoter Not Associated With Polycystic Ovary Syndrome
Diabetes,
January 1, 2003;
52(1):
214 - 217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pizzuti, A. Argiolas, R. Di Paola, R. Baratta, A. Rauseo, M. Bozzali, R. Vigneri, B. Dallapiccola, V. Trischitta, and L. Frittitta
An ATG Repeat in the 3'-Untranslated Region of the Human Resistin Gene Is Associated with a Decreased Risk of Insulin Resistance
J. Clin. Endocrinol. Metab.,
September 1, 2002;
87(9):
4403 - 4406.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|